OFI Invest Asset Management grew its stake in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 4.2% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,299,298 shares of the company's stock after buying an additional 52,562 shares during the quarter. OFI Invest Asset Management owned 0.10% of Keurig Dr Pepper worth $42,955,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Rise Advisors LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter valued at about $25,000. Chung Wu Investment Group LLC purchased a new position in shares of Keurig Dr Pepper in the 2nd quarter valued at about $26,000. WPG Advisers LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter valued at about $43,000. Continuum Advisory LLC boosted its stake in shares of Keurig Dr Pepper by 82.5% in the 1st quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after buying an additional 602 shares during the period. Finally, Global Trust Asset Management LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter valued at about $48,000. Hedge funds and other institutional investors own 93.99% of the company's stock.
Keurig Dr Pepper Price Performance
Shares of NASDAQ KDP opened at $25.82 on Friday. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper, Inc has a twelve month low of $25.03 and a twelve month high of $37.27. The stock has a 50 day moving average of $29.39 and a two-hundred day moving average of $32.23. The stock has a market cap of $35.07 billion, a P/E ratio of 23.05, a P/E/G ratio of 1.43 and a beta of 0.43.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, meeting analysts' consensus estimates of $0.49. The company had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The firm's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 earnings per share. On average, research analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were issued a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend was Friday, September 26th. Keurig Dr Pepper's dividend payout ratio is currently 82.14%.
Insiders Place Their Bets
In related news, Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction on Friday, August 1st. The stock was sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the transaction, the director owned 2,292,169 shares of the company's stock, valued at $75,412,360.10. This represents a 8.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the transaction, the insider directly owned 82,511 shares in the company, valued at $2,777,320.26. This represents a 12.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 435,601 shares of company stock worth $14,421,512 in the last ninety days. 0.40% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on the company. Citigroup cut their target price on Keurig Dr Pepper from $41.00 to $37.00 and set a "buy" rating on the stock in a research report on Tuesday, September 16th. Weiss Ratings reissued a "hold (c)" rating on shares of Keurig Dr Pepper in a research report on Wednesday. Bank of America cut their target price on Keurig Dr Pepper from $41.00 to $33.00 and set a "buy" rating on the stock in a research report on Wednesday. BNP Paribas lowered Keurig Dr Pepper from a "neutral" rating to an "underperform" rating in a research report on Monday, September 22nd. Finally, Barclays lowered Keurig Dr Pepper from an "overweight" rating to an "equal weight" rating and cut their target price for the stock from $39.00 to $26.00 in a research report on Wednesday, September 24th. Eleven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $35.00.
View Our Latest Report on Keurig Dr Pepper
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.